Study guide

3.2 Pediatric Pain Assessment Scales & Developmental Screening

Pediatric Nursing Certification PED-BC

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Exam Overview, Blueprint & Clinical Decision-Making

1.1 ANCC PED-BC Exam Facts, Scoring & Test Blueprint 1.2 The Pediatric Nursing Process & Clinical Judgment Model 1.3 Prioritization, Clinical Case Analysis & Practice Strategies

2 Chapter 2: Pediatric Growth, Development & Milestones

2.1 Infancy and Toddlerhood: Physical Growth & Motor Milestones 2.2 Preschool, School-Age & Adolescent Milestones 2.3 Developmental Theories: Erikson, Piaget, Kohlberg & Freud

3 Chapter 3: Pediatric Physical Assessment, Vital Signs & Diagnostic Screening

3.1 Pediatric Physical Examination & Age-Specific Vital Sign Norms 3.2 Pediatric Pain Assessment Scales & Developmental Screening 3.3 Pediatric Laboratory Values & Diagnostic Specimen Collection

4 Chapter 4: Pediatric Fluid, Electrolyte & Nutritional Management

4.1 Dehydration Severity, Oral Rehydration Therapy & IV Deficit Replacement 4.2 Pediatric Electrolyte Disturbances: Sodium, Potassium & Calcium Imbalances 4.3 Infant Nutrition, Formula Preparation, Failure to Thrive & Deficiencies

5 Chapter 5: Pediatric Respiratory Emergencies & Chronic Pulmonary Conditions

5.1 Upper Airway Obstruction: Croup, Epiglottitis & Foreign Body Aspiration 5.2 Lower Airway Infections: Bronchiolitis (RSV) & Pediatric Pneumonia 5.3 Chronic Pulmonary Disorders: Pediatric Asthma & Cystic Fibrosis Management

6 Chapter 6: Pediatric Congenital & Acquired Cardiovascular Disorders

6.1 Acyanotic Congenital Heart Defects: Left-to-Right Shunts & Obstructive Lesions 6.2 Cyanotic Defects & Complex Anomalies: Tetralogy of Fallot, TGA & Hypercyanotic Spells 6.3 Acquired Pediatric Heart Disease: Kawasaki Disease, Rheumatic Fever & Heart Failure

7 Chapter 7: Pediatric Neurological & Neuromuscular Disorders

7.1 Pediatric Seizure Disorders: Febrile Seizures, Epilepsy & Status Epilepticus 7.2 Central Nervous System Infections & Increased Intracranial Pressure 7.3 Structural Anomalies & Neuromuscular Disorders: Hydrocephalus, VP Shunts, Spina Bifida & Cerebral Palsy

8 Chapter 8: Pediatric Gastrointestinal & Hepatic Conditions

8.1 Acute Surgical Conditions: Pyloric Stenosis, Intussusception & Appendicitis 8.2 Congenital & Structural GI Anomalies: Cleft Lip/Palate, TEF & Hirschsprung Disease 8.3 Chronic GI & Malabsorption: Pediatric GERD, Celiac Disease & Inflammatory Bowel Disease

9 Chapter 9: Pediatric Renal & Genitourinary Conditions

9.1 Pediatric Urinary Tract Infections, Vesicoureteral Reflux & Enuresis 9.2 Glomerular Disorders: Minimal Change Nephrotic Syndrome & Acute Post-Streptococcal Glomerulonephritis 9.3 Hemolytic Uremic Syndrome, Acute Kidney Injury & Structural Genital Anomalies

10 Chapter 10: Pediatric Hematologic & Oncologic Conditions

10.1 Pediatric Anemias & Sickle Cell Disease Crises 10.2 Pediatric Bleeding Disorders: Hemophilia A/B & Immune Thrombocytopenia 10.3 Pediatric Leukemias, Solid Tumors & Oncologic Emergencies

11 Chapter 11: Pediatric Endocrine & Inborn Metabolic Disorders

11.1 Pediatric Type 1 Diabetes Mellitus & Diabetic Ketoacidosis Protocols 11.2 Pediatric Thyroid, Adrenal & Growth Hormone Disorders 11.3 Inborn Errors of Metabolism & Pubertal Disorders: PKU, Galactosemia & Precocious Puberty

12 Chapter 12: Pediatric Musculoskeletal, Integumentary & Infectious Disorders

12.1 Pediatric Orthopedics: Developmental Dysplasia of the Hip, Clubfoot, Scoliosis & Fractures 12.2 Pediatric Burns, Atopic Dermatitis & Dermatologic Conditions 12.3 Viral Exanthems, Communicable Diseases & Pediatric Sepsis Management

13 Chapter 13: Pediatric Pharmacology, Safe Dosage & Immunizations

13.1 Pediatric Pharmacokinetics, Weight-Based Calculations & Safe Dosing Limits 13.2 High-Alert Pediatric Medications, IV Infusion Safety & Vascular Access 13.3 CDC Childhood Immunization Schedules, Vaccine Safety & Catch-Up Guidelines

14 Chapter 14: Family-Centered Care, Psychosocial Health & Injury Prevention

14.1 Family-Centered Care Principles, Hospitalization Stress & Separation Anxiety 14.2 Developmentally Appropriate Procedural Preparation & Non-Pharmacological Comfort 14.3 Anticipatory Guidance, Car Seat Safety, Drowning & Poisoning Prevention

15 Chapter 15: Professional Role, Ethics, Legal Standards & Advocacy

15.1 Informed Consent, Minor Assent & Adolescent Confidentiality Rights 15.2 Mandatory Reporting: Identifying Child Abuse, Neglect & Human Trafficking 15.3 Evidence-Based Practice, Pediatric Quality Metrics & Interprofessional Collaboration

16 Chapter 16: Medication Reconciliation, Complementary Care & Interactions

16.1 Medication, Allergy & Treatment Reconciliation 16.2 Complementary Products & Treatment Interactions

17 Chapter 17: Individualized Assessment, Diversity & Psychosocial Safety

17.1 Culture, Resources, Religion & Individualized Care 17.2 Psychosocial Screening & Immediate Mental Health Safety

18 Chapter 18: Individualized Planning, Coordination & Family Teaching

18.1 Measurable Outcomes, Coordination & Delegation 18.2 Teach-Back, Return Demonstration & Learning Evaluation

19 Chapter 19: Patient Safety, Chronic Care & Outcome Evaluation

19.1 Withdrawal, Elopement, De-escalation & Risk Reduction 19.2 Chronic Care, Healthy Weight & Response Evaluation

3.2 Pediatric Pain Assessment Scales & Developmental Screening

Key Takeaways Explain This Topic AI

Patient self-report is the recognized clinical gold standard for pain assessment, but validated behavioral observation scales (NPASS, CRIES, FLACC) must be utilized for neonates, pre-verbal infants, and cognitively impaired children.

The FLACC scale evaluates five behavioral categories (Face, Legs, Activity, Cry, Consolability) scored 0 to 2 each for a total score of 0 to 10; it is validated for non-verbal children and ages 2 months to 7 years.

Self-report scales must match developmental readiness: the Wong-Baker FACES Pain Rating Scale is appropriate for children aged 3 to 4 years and older, whereas the Numeric Rating Scale (0 to 10) requires understanding of numbers and relative magnitude and is validated for ages 8 years and older.

The American Academy of Pediatrics (AAP) mandates standardized developmental screening at 9, 18, and 30 months using validated tools like the ASQ-3 or Denver II, alongside universal autism screening with the M-CHAT-R/F at 18 and 24 months.

The Joint Committee on Infant Hearing (JCIH) 1-3-6 benchmark requires newborn hearing screening by 1 month of age, diagnostic audiological evaluation by 3 months, and early intervention enrollment by 6 months.

Last updated: October 2026

Pediatric Pain Assessment Scales & Developmental Screening

Accurate pain assessment and developmental screening are fundamental cornerstones of pediatric nursing practice. Historically, pediatric patients suffered from widespread undertreatment of pain based on erroneous beliefs that immature nervous systems did not perceive noxious stimuli. Contemporary neurobiology proves that nociceptive pathways are fully functional by 24 weeks of gestation, while descending inhibitory pathways remain underdeveloped. Consequently, infants and young children experience heightened pain sensitivity and long-term neurodevelopmental consequences if acute pain is left unmanaged.

1. Principles of Pediatric Pain Assessment

Pain is subjective and multifaceted. The pediatric nurse must adhere to a standardized clinical hierarchy when assessing pain:

Self-Report: Always the clinical gold standard whenever a child has the cognitive and communicative ability to report pain severity.

Behavioral Observations: Utilized when the child cannot self-report due to age, sedation, critical illness, or cognitive impairment. Behaviors include facial grimacing, motor restlessness, crying, guarding, and inability to be consoled.

Physiological Indicators: Tachycardia, tachypnea, hypertension, pupillary dilation, diaphoresis, and oxygen desaturation. Caution: Physiological markers habituate rapidly during sustained pain, reflect generalized stress or hypoxia, and must never be used alone to dismiss the presence of pain.

2. Neonatal & Pre-Verbal Infant Pain Scales

Neonates and young infants require specialized, validated observational tools tailored to their neurodevelopmental stage.

NPASS (Neonatal Pain, Agitation, and Sedation Scale)

Target Population: Preterm and full-term neonates in neonatal intensive care units (NICUs) and infant wards up to 100 days of age.

Unique Clinical Feature: It assesses both acute pain/agitation (positive scores: 0 to +2 per item, total score 0 to 10) AND depth of sedation (negative scores: 0 to -2 per item, total score 0 to -10). This dual assessment makes it ideal for evaluating mechanically ventilated infants receiving continuous opioid or sedative infusions.

Five Scored Domains:

  • Crying / Irritability
  • Behavioral State
  • Facial Expression
  • Extremities / Muscle Tone
  • Vital Signs (Heart Rate, Respiratory Rate, Blood Pressure, SaO2)

Prematurity Weighting: Infants born at < 28 weeks gestation receive +2 additional points, and those at 28 to 31 weeks receive +1 additional point to compensate for diminished behavioral reserve.

CRIES Scale

Target Population: Full-term and preterm infants born at 32 weeks gestation or older , particularly validated for postoperative surgical pain .

Scoring Structure: 5 categories scored 0, 1, or 2 (Total score: 0 to 10):

C - Crying: 0 = No cry; 1 = High-pitched cry, consolable; 2 = High-pitched cry, inconsolable.

R - Requires O2 for SaO2 > 95%: 0 = Room air; 1 = < 30% FiO2 required; 2 = > 30% FiO2 required.

I - Increased Vital Signs: 0 = Heart rate and blood pressure equal to or below baseline; 1 = HR or BP elevated < 20% over baseline; 2 = HR or BP elevated > 20% over baseline.

E - Expression (Facial): 0 = Relaxed; 1 = Grimace present; 2 = Grimace with non-cry grunt.

S - Sleeplessness: 0 = Sleeps continuously; 1 = Awakens at frequent intervals; 2 = Constantly awake.

Clinical Action Threshold: A score > 4 indicates significant pain requiring analgesia.

PIPP (Premature Infant Pain Profile)

Incorporates gestational age, baseline behavioral state, heart rate, oxygen saturation, and three specific facial actions: brow bulge, eye squeeze, and nasolabial furrow .

3. The FLACC Behavioral Pain Scale

The FLACC Scale (Face, Legs, Activity, Cry, Consolability) is the most widely utilized and validated observational pain instrument in pediatric nursing. It is indicated for infants and children aged 2 months to 7 years , non-verbal pediatric patients, cognitively impaired children, and patients emerging from general anesthesia in the post-anesthesia care unit (PACU).

Category Score 0 Score 1 Score 2

Face No particular expression or smile; relaxed Occasional grimace or frown, withdrawn, disinterested Frequent to constant quivering chin, clenched jaw, deeply furrowed brow

Legs Normal position or relaxed; free movement Uneasy, restless, tense, intermittent leg flexion Kicking, or legs drawn up tightly against abdomen; spasticity

Activity Lying quietly, normal position, moves easily Squirming, shifting back and forth, tense, guarded Arched, rigid, or jerking; stiff posture, striking out

Cry No cry (awake or asleep) Moans or whimpers; occasional complaint Crying steadily, screams or sobs; frequent complaints

Consolability Content, relaxed, calm Reassured by occasional touching, hugging, or talking; distractible Difficult to console or comfort; inconsolable, pushes caregiver away

Clinical Interpretation and Actions

Score 0: Relaxed and comfortable (no pain intervention required).

Score 1 to 3: Mild discomfort (initiate comfort measures, repositioning, non-pharmacologic modalities; consider non-opioid analgesics like acetaminophen or ibuprofen).

Score 4 to 6: Moderate pain (administer prescribed systemic analgesia, reassess within 30 to 60 minutes).

Score 7 to 10: Severe discomfort or pain (prompt multimodal analgesia, parenteral opioids as ordered, rapid reassessment).

The Revised FLACC (r-FLACC)

For children with severe cognitive or physical impairments (e.g., severe cerebral palsy), the standard FLACC is modified into the r-FLACC . In the r-FLACC, the nurse collaborates directly with the primary family caregiver to document individualized, baseline behavioral indicators of pain (such as idiosyncratic vocalizations, specific head-banging movements, or unique facial grimaces).

4. Self-Report Pain Scales for Verbal Children

Self-report should be implemented as early as developmental cognition permits. The nurse must select the tool that matches the child's numerical and abstract cognitive abilities.

Instrument Name Validated Age Group Scale Format & Architecture Key Nursing Administration Pearls

Wong-Baker FACES Ages 3 to 4 years and older Six cartoon faces depicting graduated distress: 0 ("No Hurt"), 2 ("Hurts Little Bit"), 4 ("Hurts Little More"), 6 ("Hurts Even More"), 8 ("Hurts Whole Lot"), 10 ("Hurts Worst") Instruct the child: "Each face belongs to a person who has no pain, a little pain, or a lot of pain. Point to the face that shows how you feel inside right now." Never use this scale to match the child's actual facial appearance; it is strictly a self-report tool.

Oucher Scale Ages 3 to 12 years Vertical poster with a numerical scale (0 to 100) alongside six photographic images of children exhibiting graduated pain distress Available in culturally specific photographic versions (Caucasian, African American, Hispanic, Asian). Younger children (ages 3 to 6) use the photos; older children with numerical literacy use the 0 to 100 scale.

Numeric Rating Scale (NRS) Ages 8 years and older Linear scale from 0 to 10, where 0 represents "No Pain" and 10 represents the "Worst Possible Pain" Requires Piagetian concrete operational cognition : the child must grasp numerical magnitude, rank order, and abstract relative intensity. Do not use in preschoolers.

Visual Analog Scale (VAS) Ages 8 to 10 years and older A 100 mm horizontal line anchored by "No Pain" at the far left and "Worst Pain Imaginable" at the far right The child places a mark along the line; the nurse measures the distance from the zero anchor in millimeters. Commonly used in clinical research and older adolescents.

  • 5. Developmental Surveillance & Standardized Screening
  • Developmental Surveillance vs. Formal Screening

Developmental Surveillance: A flexible, continuous, longitudinal process conducted at every single preventive well-child visit . It includes eliciting parental concerns, obtaining an updated developmental history, observing parent-child interactions, and identifying risk factors.

Standardized Developmental Screening: The formal administration of an established, validated, norm-referenced screening tool. The American Academy of Pediatrics (AAP) recommends universal standardized developmental screening at:

  • 9 months of age
  • 18 months of age
  • 30 months of age (or at 24 months if a 30-month visit is unavailable)
  • Common Standardized Developmental Tools

Ages & Stages Questionnaires, Third Edition (ASQ-3): A parent-completed developmental screening system covering ages 1 month to 5.5 years (66 months). It evaluates five distinct domains:

Communication: Vocalizations, language comprehension, and verbal expression.

Gross Motor: Arm, leg, and postural body movements.

Fine Motor: Hand and finger grasp, eye-hand coordination.

Problem Solving: Learning, manipulation of objects, and cognitive problem-solving.

Personal-Social: Solitary and interactive social play, self-help skills (feeding, dressing).

Scoring: Total domain scores falling below established empirical cutoff lines indicate suspected developmental delay, requiring immediate referral to state-sponsored Part C Early Intervention services.

Denver Developmental Screening Test II (Denver II): An examiner-administered tool evaluating 125 functional items across four streams: Personal-Social, Fine Motor-Adaptive, Language, and Gross Motor from birth through 6 years of age. Identifies developmental "cautions" and "delays."

6. Universal Autism Spectrum Disorder (ASD) Screening: M-CHAT-R/F

The AAP mandates universal screening for Autism Spectrum Disorder (ASD) at 18 months and 24 months of age , or at any time a parent or clinician raises concerns regarding social communication.

Architecture of the M-CHAT-R/F

The Modified Checklist for Autism in Toddlers, Revised with Follow-Up (M-CHAT-R/F) is a 20-item, parent-completed screening tool focusing on joint attention, social reciprocity, and communication behaviors (e.g., pointing to show interest, eye contact, responding to name, bringing objects to show parents).

Scoring Algorithm & Clinical Risk Tiers

Low Risk (Total Score: 0 to 2):

Action: If the child is younger than 24 months, rescreen at the 24-month well visit. No further diagnostic action needed unless clinical surveillance reveals red flags.

Medium Risk (Total Score: 3 to 7):

Action: Administer the structured M-CHAT-R/F Follow-Up Interview (in person or via telephone) for each failed item.

If the follow-up score remains ≥ 2 , the screen is considered positive: immediately refer the child for comprehensive diagnostic evaluation and early intervention.

If the follow-up score is 0 to 1 , the screen is considered passed; rescreen at subsequent visits as indicated.

High Risk (Total Score: 8 to 20):

Action: Bypass the follow-up interview! The child has screened strongly positive. Immediately refer for a comprehensive multidisciplinary autism evaluation and simultaneously enroll in state Part C Early Intervention services. Never delay referral to "wait and see"!

  • 7. Pediatric Sensory Screening: Vision & Hearing
  • Vision Screening Guidelines

Newborn to 3 Years:

Red Reflex Test (Bruckner Test): Inspect both eyes simultaneously using a direct ophthalmoscope set at 0 diopters from a distance of 18 to 24 inches in a darkened room. Normal red reflex is bright, symmetric, and reddish-orange. Absence of red reflex or presence of an abnormal white reflex (leukocoria) is an absolute medical emergency , indicating retinoblastoma, congenital cataracts, or persistent fetal vasculature.

Fixation & Following: Term infants fixate on faces by 4 to 6 weeks and track objects smoothly across 180 degrees by 3 to 4 months.

Strabismus Evaluation: Utilize the corneal light reflex (Hirschberg test) and the cover-uncover test . Intermittent strabismus is common in early infancy, but persistent or new-onset strabismus after 4 to 6 months is abnormal and requires pediatric ophthalmology referral to prevent irreversible cortical amblyopia (lazy eye).

Visual Acuity Testing (Ages 3 Years and Older):

Ages 3 to 5: Use standardized optotypes including LEA Symbols (circle, square, apple, house) or HOTV matching charts .

Ages 6 and older: Utilize the standard Snellen letter chart .

Referral Criteria for Ophthalmology:

Age 3 to 4 years: Visual acuity worse than 20/40 in either eye.

Age 5 years: Visual acuity worse than 20/30 in either eye.

Any Age: A difference of two or more lines between eyes (e.g., 20/25 in one eye and 20/40 in the other), even if the weaker eye passes the minimum threshold.

Hearing Screening Guidelines & The JCIH 1-3-6 Benchmark

Universal Newborn Hearing Screening (UNHS): Performed before nursery discharge using Otoacoustic Emissions (OAE) or Automated Auditory Brainstem Response (AABR) .

The Joint Committee on Infant Hearing (JCIH) 1-3-6 Rule:

"1" (By 1 Month): Universal hearing screening completed for all infants prior to hospital discharge or before 1 month of life.

"3" (By 3 Months): Comprehensive diagnostic audiological evaluation completed for all infants who fail the initial screen.

"6" (By 6 Months): Comprehensive family-centered early intervention services initiated for all infants with confirmed sensorineural or conductive hearing loss to safeguard speech and language development.

Pure-Tone Audiometric Screening: Performed annually at preventive well visits at ages 4, 5, 6, 8, and 10 years , and once during middle school and high school. The child is tested at 1000, 2000, and 4000 Hz at a 20 dB HL threshold.

Loading diagram... Developmental Pediatric Pain Assessment Tool Selection